FDA Approved: URSO 250 — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for URSO 250 (ursodiol) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Gallstone Disease

Drugs mentioned

• URSO 250 (ursodiol)

Snippet

SUPPL AP for URSO 250 (URSODIOL)